WOOJUNG BIO Inc (215380) — Financial Flexibility Index
WOOJUNG BIO Inc (215380) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of ₩-809.75 Million (operating CF ₩-809.75 Million minus capex ₩0.00) represents 0% of total liabilities (₩65.22 Billion). Check 215380 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
WOOJUNG BIO Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for WOOJUNG BIO Inc across 9 annual periods. See WOOJUNG BIO Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for WOOJUNG BIO Inc (2016–2024)
Year-by-year free cash flow to debt coverage for WOOJUNG BIO Inc. For the full company profile including market capitalisation, see 215380 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | ₩-816.92 Million | ₩-1.13 Billion | ₩65.33 Billion | ▲ +59.1% |
| 2023 | -0.03x | ₩-2.33 Billion | ₩-3.22 Billion | ₩76.36 Billion | ▼ -114.3% |
| 2022 | 0.21x | ₩13.92 Billion | ₩2.50 Billion | ₩65.28 Billion | ▼ -61.9% |
| 2021 | 0.56x | ₩38.41 Billion | ₩1.73 Billion | ₩68.68 Billion | ▲ +225.0% |
| 2020 | 0.17x | ₩7.19 Billion | ₩-8.57 Billion | ₩41.78 Billion | ▲ +124.9% |
| 2019 | 0.08x | ₩2.37 Billion | ₩208.72 Million | ₩30.97 Billion | ▼ -56.9% |
| 2018 | 0.18x | ₩4.19 Billion | ₩-483.80 Million | ₩23.61 Billion | ▲ +304.0% |
| 2017 | -0.09x | ₩-1.14 Billion | ₩-2.38 Billion | ₩13.07 Billion | ▲ +1.7% |
| 2016 | -0.09x | ₩-126.76 Million | ₩-1.46 Billion | ₩1.43 Billion | — |